20.2 Detecting Antigen-Antibody Complexes

Serological Tests and Antigen-Antibody Complexes

Serological tests diagnose diseases by detecting antigens or antibodies in blood. They work because antigens and antibodies form visible complexes under the right conditions, and the pattern of those reactions tells you what's going on in a patient's immune system. The core challenge is getting the conditions right so you can trust your results.

Precipitation vs. Agglutination Assays

These are two fundamental ways to visualize antigen-antibody complex formation. The difference comes down to whether the antigen starts out dissolved in solution or attached to a particle.

Precipitation assays involve soluble antigens reacting with antibodies in solution. When enough antibody-antigen bonds form, the complexes grow large enough to become insoluble and settle out, producing a visible cloudiness or precipitate.

• Immunodiffusion (Ouchterlony test): Antigen and antibody are placed in separate wells cut into an agar gel. They diffuse toward each other, and where they meet at optimal concentrations, a visible line of precipitate forms.
• Immunoelectrophoresis: Combines electrophoresis (separating proteins by charge) with immunodiffusion to identify specific proteins in a mixture.

Agglutination assays use particulate antigens, meaning the antigen is on the surface of something visible, like red blood cells or latex beads. Antibodies cross-link these particles, causing them to clump together (agglutinate). The clumping is easy to see with the naked eye, making these tests fast and practical.

• Blood typing (ABO): Anti-A or Anti-B antibodies are mixed with a patient's red blood cells. Clumping tells you which surface antigens are present.
• Widal test: Detects antibodies against Salmonella by mixing patient serum with bacterial antigens.
• Latex agglutination: Latex beads coated with a known antigen (or antibody) clump when the corresponding partner is present in the sample. Used for rapid diagnosis of conditions like strep throat.

Antigen-Antibody Ratios in Complex Formation

Visible complex formation depends on having the right proportions of antigen and antibody. Too much of either one actually prevents a visible reaction, which can cause you to miss a positive result.

• Prozone effect (antibody excess): When there are far more antibodies than antigens, each antigen gets saturated with antibodies before cross-linking can occur. The resulting complexes are too small to precipitate or agglutinate. This produces a false-negative result. To avoid it, labs serially dilute the serum before testing.
• Equivalence zone: This is the sweet spot where antigen and antibody are in optimal proportion. Maximum cross-linking occurs, forming large, insoluble lattice-like complexes. You get the strongest visible reaction and the most reliable results here.
• Postzone effect (antigen excess): When antigens far outnumber antibodies, each antibody binds only one or two antigen molecules without forming large cross-linked networks. Again, complexes stay small and soluble, giving another false-negative.

Antibodies in Serological Diagnostics

Serological tests exploit the specificity of antibodies, which recognize particular regions on antigens called epitopes. Depending on the clinical question, you can test for either the antibody or the antigen.

Antibody detection tests look for antibodies the patient's immune system has made in response to a pathogen. A positive result means the patient has been exposed at some point (recent or past). These are commonly used for HIV screening and syphilis diagnosis, and they're helpful for chronic infections where the pathogen may be hard to culture.

Antigen detection tests look for pathogen-derived molecules directly. A positive result points to active infection, since the pathogen's antigens are present only while it's replicating. These are especially valuable early in infection, before the patient has mounted a detectable antibody response. Examples include tests for bacterial capsular antigens in cerebrospinal fluid and rapid viral antigen tests.

Antibody titer determination quantifies how much specific antibody is in a patient's serum:

1. The serum is serially diluted (1:2, 1:4, 1:8, 1:16, and so on).
2. Each dilution is tested for a positive reaction (precipitation or agglutination).
3. The titer is reported as the reciprocal of the highest dilution that still shows a positive result. For example, if the last positive reaction is at 1:160, the titer is 160.

High titers generally suggest recent or active infection. A four-fold increase in titer between acute and convalescent serum samples (drawn weeks apart) is considered strong evidence of a current infection. Low or stable titers may reflect past exposure or vaccination.

Cross-reactivity is a potential pitfall. Antibodies sometimes bind epitopes on unrelated antigens that happen to share a similar shape, leading to false-positive results. This is why confirmatory tests (like Western blot) exist.

Advanced Serological Techniques

These methods offer greater sensitivity and specificity than basic precipitation or agglutination assays.

Enzyme-Linked Immunosorbent Assay (ELISA) is one of the most widely used serological tests. It detects and quantifies specific antigens or antibodies using enzyme-labeled antibodies that produce a color change. The intensity of the color is proportional to the amount of target molecule present, allowing both qualitative (positive/negative) and quantitative results.

Western blot separates proteins by size using gel electrophoresis, then transfers them to a membrane where they're probed with specific antibodies. It's commonly used as a confirmatory test after a positive ELISA screen, since it can identify the exact proteins the patient's antibodies are reacting with.

Immunofluorescence uses antibodies tagged with fluorescent dyes to visualize antigen-antibody binding in tissue sections or cell samples under a fluorescence microscope. This is useful for detecting pathogens directly in patient tissues or for identifying autoantibodies.

Monoclonal antibodies are lab-produced antibodies that all recognize a single, specific epitope. Because of this uniformity, they provide highly consistent and specific results. They're used across ELISA, Western blot, and immunofluorescence to reduce cross-reactivity and improve diagnostic accuracy.

• The specific binding site on the antibody that contacts the epitope is called the paratope. Think of it as the lock-and-key counterpart: the epitope is the region on the antigen, and the paratope is the matching region on the antibody.